- Cost Curve
- Posts
- Lilly Says Lists Prices Rose 3.8% Last Year, Though the Net Prices Tell a More Fascinating Story
Lilly Says Lists Prices Rose 3.8% Last Year, Though the Net Prices Tell a More Fascinating Story
And IQVIA is out with its annual assessment of 340B: The program is huge and getting big fast
Jun 9, 2025
Subscribe to Cost Curve Apex to read the rest.
Upgrade to Apex to get access to this post and other subscriber-only content.
UpgradeKeep Reading
No posts found
